The YouTube ‘hit job’ making its way through biotech circles
(YOUTUBE)
In a short film that invokes Chernobyl, Homer Simpson, and the aesthetics of early-2000s video-editing software, someone is trying to tarnish the reputation of Jacobus Pharmaceuticals.
As STAT’s Ed Silverman reports, earlier this month, a YouTube account called “Bad Pharma Exposed” posted a roughly six-minute video pointing out that Jacobus’s New Jersey manufacturing plant is right next to a decommissioned nuclear reactor. Then there’s some ominous music, animated text, and snippets from old FDA inspection reports, all making the case that Jacobus’s drugs might not be safe.
The video, which one analyst called “a well-done hit job,” doesn’t break any new ground on Jacobus. But the timing is curious. Jacobus made headlines back in 2019 when it won FDA approval for a drug that treats the rare disease LEMS. Before that, Catalyst Pharmaceuticals had the only approved LEMS treatment, a drug that costs $375,000 or more. Catalyst has since sued the FDA, claiming it “arbitrarily and capriciously” approved the Jacobus drug, which sells for less than half the price. A federal judge has promised to rule on the lawsuit.
Read more.
As STAT’s Ed Silverman reports, earlier this month, a YouTube account called “Bad Pharma Exposed” posted a roughly six-minute video pointing out that Jacobus’s New Jersey manufacturing plant is right next to a decommissioned nuclear reactor. Then there’s some ominous music, animated text, and snippets from old FDA inspection reports, all making the case that Jacobus’s drugs might not be safe.
The video, which one analyst called “a well-done hit job,” doesn’t break any new ground on Jacobus. But the timing is curious. Jacobus made headlines back in 2019 when it won FDA approval for a drug that treats the rare disease LEMS. Before that, Catalyst Pharmaceuticals had the only approved LEMS treatment, a drug that costs $375,000 or more. Catalyst has since sued the FDA, claiming it “arbitrarily and capriciously” approved the Jacobus drug, which sells for less than half the price. A federal judge has promised to rule on the lawsuit.
Read more.
.png)
No hay comentarios:
Publicar un comentario